卡塔尔的Lillia开发了AI型慢性病治疗平台, Qatar's Lillia develops AI platform for managing chronic diseases, aided by a $1.7M grant.

卡塔尔的健康科技初创公司Lillia在QRDI的170万美元资助下, 正在开发一种人工智能平台来管理糖尿病等慢性疾病. Qatar-based healthtech startup Lillia, with a $1.7 million grant from QRDI, is developing an AI platform to manage chronic diseases like diabetes. 该平台旨在成为海合会第一个长期状况的数字双胞胎,为40 000多人提供支持,并计划在中东和北非及东南亚扩展。 The platform, aiming to be the first digital twin for chronic conditions in the GCC, supports over 40,000 people and plans to expand across MENA and Southeast Asia. Lilia以医疗保健提供者、保险公司和公共实体为目标,提供个性化疾病管理解决方案。 Lillia targets healthcare providers, insurers, and public entities, offering personalized disease management solutions.